v3.26.3
Note 13 - Segment Reporting and Geographic Information - Segment Expenses (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2026
Jun. 30, 2026
Mar. 31, 2026
Sep. 30, 2025
Jun. 30, 2025
Mar. 31, 2025
Sep. 30, 2026
Sep. 30, 2025
Clinical and pre-clinical expenses $ 676     $ 428     $ 1,742 $ 720
Patent expenses 92     169     302 644
Personnel costs 512     562     1,662 2,148
Professional services 569     233     1,398 1,587
Other operational expenses 214     248     641 756
Other segment items 1     (18)     (9) (69)
Segment net loss 2,064     1,622     5,736 5,786
Net loss (income) from discontinued operations (52,556)     3,322     (43,854) 2,637
Consolidated net loss $ (50,492) $ 5,700 $ 6,674 $ 4,944 $ 4,649 $ (1,170) $ (38,118) $ 8,423